Trump announces all 50 states joining Medicaid drug pricing model

The Trump administration has announced that all 50 states have agreed to participate in a new Medicaid prescription drug pricing model, officially titled the Medicaid GENEROUS model. The initiative is intended to reduce prescription drug expenditures within the Medicaid program, with federal officials projecting that the plan will result in billions of dollars in savings.

While the administration emphasizes the potential for significant cost reductions, the actual financial impact remains subject to debate. Industry analysts have noted that the specific terms and content of the state-level agreements have not been made public, leading some experts to characterize the projected savings as currently unclear.